HUE035416T2 - Peptide derivatives, their preparation and their vector use - Google Patents
Peptide derivatives, their preparation and their vector use Download PDFInfo
- Publication number
- HUE035416T2 HUE035416T2 HUE11731421A HUE11731421A HUE035416T2 HU E035416 T2 HUE035416 T2 HU E035416T2 HU E11731421 A HUE11731421 A HU E11731421A HU E11731421 A HUE11731421 A HU E11731421A HU E035416 T2 HUE035416 T2 HU E035416T2
- Authority
- HU
- Hungary
- Prior art keywords
- peptide
- cys
- peptides
- pseudo
- xaa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1053036A FR2959229B1 (fr) | 2010-04-21 | 2010-04-21 | Derives peptidiques, leur preparation et leurs utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE035416T2 true HUE035416T2 (en) | 2018-05-02 |
Family
ID=43365640
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE11731421A HUE035416T2 (en) | 2010-04-21 | 2011-04-18 | Peptide derivatives, their preparation and their vector use |
| HUE13783290A HUE042850T2 (hu) | 2010-04-21 | 2013-10-18 | Készítmények hatóanyag szállításra |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE13783290A HUE042850T2 (hu) | 2010-04-21 | 2013-10-18 | Készítmények hatóanyag szállításra |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8877716B2 (es) |
| EP (1) | EP2547692B1 (es) |
| JP (1) | JP6073779B2 (es) |
| CN (1) | CN103119052B (es) |
| AU (1) | AU2011244107B2 (es) |
| BR (1) | BR112012027043B1 (es) |
| CA (1) | CA2796174C (es) |
| DK (2) | DK2547692T5 (es) |
| EA (1) | EA022422B1 (es) |
| ES (2) | ES2637265T3 (es) |
| FR (1) | FR2959229B1 (es) |
| HU (2) | HUE035416T2 (es) |
| PL (1) | PL2547692T3 (es) |
| TR (1) | TR201905058T4 (es) |
| WO (1) | WO2011131896A2 (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003222568B2 (en) | 2002-01-11 | 2009-05-07 | Bioasis Technologies, Inc. | Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
| FR2937322B1 (fr) | 2008-10-22 | 2013-02-22 | Vect Horus | Derives peptidiques et leur utilisation comme vecteurs de molecules sous forme de conjugues |
| WO2014060601A1 (en) | 2012-10-19 | 2014-04-24 | Vect-Horus | Compositions and methods for drug delivery |
| FR2959229B1 (fr) | 2010-04-21 | 2013-01-18 | Vect Horus | Derives peptidiques, leur preparation et leurs utilisations |
| JP6082901B2 (ja) * | 2011-01-31 | 2017-02-22 | オリンパス株式会社 | ワクチン・アジュバント |
| BR112014002219A2 (pt) | 2011-07-05 | 2018-08-07 | Bioasis Technologies Inc | conjugados anticorpo p97 e métodos de sua utilização |
| US9932565B2 (en) | 2012-07-31 | 2018-04-03 | Bioasis Technologies, Inc. | Dephosphorylated lysosomal storage disease proteins and methods of use thereof |
| ES2774549T3 (es) | 2013-03-13 | 2020-07-21 | Bioasis Technologies Inc | Fragmentos de P97 y usos de los mismos |
| CN104117069A (zh) * | 2013-04-26 | 2014-10-29 | 复旦大学 | 一种针对脑胶质瘤的靶向纳米递药系统及其制备方法和应用 |
| US20150093399A1 (en) | 2013-08-28 | 2015-04-02 | Bioasis Technologies, Inc. | Cns-targeted conjugates having modified fc regions and methods of use thereof |
| EP2896402A1 (en) * | 2014-01-20 | 2015-07-22 | Vect-Horus | Activated neurotensin molecules and the uses thereof |
| US20160347821A1 (en) | 2014-02-03 | 2016-12-01 | Bioasis Technologies, Inc. | P97 fusion proteins |
| DK3107562T3 (da) | 2014-02-19 | 2019-12-16 | Bioasis Technologies Inc | P97-ids-fusionsproteiner |
| CN106413757B (zh) | 2014-05-01 | 2022-01-14 | 比奥阿赛斯技术有限公司 | p97-多核苷酸结合物 |
| US20160215031A1 (en) * | 2015-01-27 | 2016-07-28 | Nymox Pharnaceutical Corporation | Method of treating disorders requiring destruction or removal of cells |
| KR101966246B1 (ko) * | 2015-11-17 | 2019-04-05 | 서울대학교산학협력단 | FCHo1 조절제를 포함하는 세포 분열 조절용 조성물 및 이를 이용한 세포 분열 조절 방법 |
| IL265352B2 (en) * | 2016-09-13 | 2024-05-01 | Angiocrine Bioscience Inc | Blood brain barrier containing engineered endothelial cells |
| CN110312549B (zh) | 2016-12-19 | 2021-06-29 | 莫尔豪斯医学院 | 用于通过抑制外泌体释放来治疗疾病的组合物和方法 |
| CN110536705A (zh) * | 2017-01-30 | 2019-12-03 | 维克塔-霍洛斯公司 | 用于癌症成像和放疗的组合物和方法 |
| US10688191B2 (en) | 2018-01-19 | 2020-06-23 | Hr Biomed, Llc | Delivery of a chemotherapy agent across the blood-brain barrier |
| WO2019221576A1 (ko) * | 2018-05-17 | 2019-11-21 | 광주과학기술원 | Ccn5를 유효성분으로 포함하는 망막질환 예방 또는 치료용 약학 조성물 |
| EA202191893A1 (ru) | 2019-01-09 | 2021-12-02 | Вект-Орус | Молекулы, связывающие рецептор трансферрина, их конъюгаты и их применение |
| CA3128035A1 (en) | 2020-08-13 | 2022-02-13 | Bioasis Technologies, Inc. | Combination therapies for delivery across the blood brain barrier |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999047566A1 (en) | 1998-03-17 | 1999-09-23 | The Uab Research Foundation | Synthetic peptides that enhance ldl uptake |
| US20040031072A1 (en) * | 1999-05-06 | 2004-02-12 | La Rosa Thomas J. | Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
| US20110131679A2 (en) * | 2000-04-19 | 2011-06-02 | Thomas La Rosa | Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
| JP2004520803A (ja) * | 2000-04-21 | 2004-07-15 | コリクサ コーポレイション | 尋常性挫瘡の治療および診断のための組成物および方法 |
| CN1388131A (zh) * | 2002-06-10 | 2003-01-01 | 牛勃 | 系列新型药物载体、新型载体－酪氨酸羟化酶融合蛋白及其制备 |
| AU2003286870A1 (en) * | 2003-06-05 | 2005-01-04 | Salk Institute For Biological Studies | Targeting polypeptides to the central nervous system |
| AR053269A1 (es) * | 2005-05-16 | 2007-04-25 | Monsanto Technology Llc | Plantas y semillas de maiz con mejoramiento de asparagina y proteina |
| CN101490270A (zh) * | 2005-07-19 | 2009-07-22 | 伊利诺斯大学理事会 | 用于穿越血脑屏障并进入脑部癌细胞的转运剂及其使用方法 |
| FR2889532B1 (fr) | 2005-08-03 | 2007-10-12 | Lab Francais Du Fractionnement | Anticorps diriges contre le recepteur du ldl |
| FR2937322B1 (fr) * | 2008-10-22 | 2013-02-22 | Vect Horus | Derives peptidiques et leur utilisation comme vecteurs de molecules sous forme de conjugues |
| FR2959229B1 (fr) | 2010-04-21 | 2013-01-18 | Vect Horus | Derives peptidiques, leur preparation et leurs utilisations |
-
2010
- 2010-04-21 FR FR1053036A patent/FR2959229B1/fr active Active
-
2011
- 2011-04-18 WO PCT/FR2011/050883 patent/WO2011131896A2/fr active Application Filing
- 2011-04-18 EA EA201201446A patent/EA022422B1/ru not_active IP Right Cessation
- 2011-04-18 CA CA2796174A patent/CA2796174C/en active Active
- 2011-04-18 PL PL11731421T patent/PL2547692T3/pl unknown
- 2011-04-18 CN CN201180030014.2A patent/CN103119052B/zh active Active
- 2011-04-18 JP JP2013505522A patent/JP6073779B2/ja active Active
- 2011-04-18 DK DK11731421.1T patent/DK2547692T5/en active
- 2011-04-18 ES ES11731421.1T patent/ES2637265T3/es active Active
- 2011-04-18 AU AU2011244107A patent/AU2011244107B2/en active Active
- 2011-04-18 HU HUE11731421A patent/HUE035416T2/en unknown
- 2011-04-18 BR BR112012027043-5A patent/BR112012027043B1/pt active IP Right Grant
- 2011-04-18 EP EP11731421.1A patent/EP2547692B1/fr active Active
-
2012
- 2012-10-19 US US13/655,954 patent/US8877716B2/en active Active
-
2013
- 2013-10-18 DK DK13783290.3T patent/DK2908837T3/en active
- 2013-10-18 TR TR2019/05058T patent/TR201905058T4/tr unknown
- 2013-10-18 ES ES13783290T patent/ES2719727T3/es active Active
- 2013-10-18 HU HUE13783290A patent/HUE042850T2/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN103119052A (zh) | 2013-05-22 |
| AU2011244107B2 (en) | 2015-07-16 |
| US8877716B2 (en) | 2014-11-04 |
| FR2959229B1 (fr) | 2013-01-18 |
| US20130108548A1 (en) | 2013-05-02 |
| TR201905058T4 (tr) | 2019-05-21 |
| CA2796174A1 (en) | 2011-10-27 |
| HUE042850T2 (hu) | 2019-07-29 |
| JP2013525336A (ja) | 2013-06-20 |
| DK2547692T5 (en) | 2017-09-25 |
| EP2547692A2 (fr) | 2013-01-23 |
| PL2547692T3 (pl) | 2018-08-31 |
| FR2959229A1 (fr) | 2011-10-28 |
| JP6073779B2 (ja) | 2017-02-01 |
| CN103119052B (zh) | 2016-06-01 |
| EA201201446A1 (ru) | 2013-04-30 |
| WO2011131896A3 (fr) | 2012-01-19 |
| BR112012027043B1 (pt) | 2022-03-22 |
| EP2547692B1 (fr) | 2017-05-17 |
| WO2011131896A2 (fr) | 2011-10-27 |
| AU2011244107A1 (en) | 2012-11-08 |
| DK2908837T3 (en) | 2019-04-23 |
| CA2796174C (en) | 2018-07-17 |
| ES2637265T3 (es) | 2017-10-11 |
| EA022422B1 (ru) | 2015-12-30 |
| BR112012027043A2 (pt) | 2016-12-06 |
| DK2547692T3 (en) | 2017-09-04 |
| ES2719727T3 (es) | 2019-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE035416T2 (en) | Peptide derivatives, their preparation and their vector use | |
| ES2525649T3 (es) | Derivados peptídicos y su uso como vectores de moléculas en forma de conjugados | |
| Raha et al. | Peptide‐mediated cancer targeting of nanoconjugates | |
| CN113453720A (zh) | 双配体药物偶联体及其用途 | |
| EP1819723A2 (en) | Drug delivery peptides for crossing blood-brain barrier | |
| Yu et al. | New cell-penetrating peptide (KRP) with multiple physicochemical properties endows doxorubicin with tumor targeting and improves its therapeutic index | |
| EP1626090B1 (en) | Novel virus vector | |
| KR20110053119A (ko) | 뇌혈관 장벽을 통과하여 퇴행성 뇌신경 질환 부위의 세포사멸을 표적하는 펩타이드 및 이의 용도 | |
| CN105050612B (zh) | 用于药物递送的组合物和方法 | |
| Meerovich et al. | Direct solid-phase peptide synthesis on chitosan microparticles for targeting tumor cells | |
| US20220362278A1 (en) | Renal targeting-type drug delivery carrier having excellent biodegrability | |
| van Rooy | Targeted liposomes for drug delivery across the blood-brain barrier | |
| KR20200135224A (ko) | 마이셀 구조의 나노 전달체 및 이의 용도 | |
| Hsueh | Trafficking of Targeted Elastin-Like Polypeptide Nanoparticles in the Lacrimal Gland |